Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |